Decreased serum tryptophan and elevated neopterin levels in systemic sclerosis. 1995

I Csipô, and L Czirják, and S Szántó, and L Szerafin, and S Sipka, and G Szegedi

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001708 Biopterins Pterin derivatives based on 2-amino-6-(1,2-dihydroxypropyl)-4(1H)-pteridinone. Biopterins are natural products that have been considered as growth factors for some insects. Biopterins are cofactors for the AROMATIC AMINO ACID hydroxylases and NITRIC OXIDE SYNTHASE. Deficiencies in BIOPTERINS metabolism (e.g., lowered TETRAHYDROBIOPTERIN) are associated with neurological deterioration (e.g., HYPERPHENYLALANINAEMIA). 2-Amino-6-((1S,2R)-1,2-dihydroxypropyl)-4(1H)-pteridinone,2-Amino-6-((1S,2S)-1,2-dihydroxypropyl)-4(1H)-pteridinone,2-Amino-6-(1,2-dihydroxypropyl)-4(8H)-pteridinone,2-amino-6-((1R,2R)-1,2-dihydroxypropyl)-4(3H)-pteridinone,4(1H)-Pteridinone, 2-amino-6-(1,2-dihydroxypropyl)-, (S-(R*,S*))-,6-Biopterin,Biopterin,D-threo-Biopterin,L-Biopterin,L-erythro-Biopterin,L-threo-Biopterin,2-Amino-6-(1,2-dihydroxypropyl)-4(1H)-pteridinone,Dictyopterin,Orinapterin,6 Biopterin,D threo Biopterin,L Biopterin,L erythro Biopterin,L threo Biopterin
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis
D014364 Tryptophan An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals. Ardeydorm,Ardeytropin,L-Tryptophan,L-Tryptophan-ratiopharm,Levotryptophan,Lyphan,Naturruhe,Optimax,PMS-Tryptophan,Trofan,Tryptacin,Tryptan,Tryptophan Metabolism Alterations,ratio-Tryptophan,L Tryptophan,L Tryptophan ratiopharm,PMS Tryptophan,ratio Tryptophan
D019798 Neopterin A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of BIOPTERINS. 2-Amino-6-(1,2,3-trihydroxypropyl)-4(3H)-pteridinone,Monapterin,Neopterin, (R*, R*)-Isomer,Neopterin, (erythro-D)-Isomer,Neopterin, (erythro-L)-Isomer,Neopterin, (threo-D)-Isomer,Neopterin, (threo-L)-Isomer,Umanopterin

Related Publications

I Csipô, and L Czirják, and S Szántó, and L Szerafin, and S Sipka, and G Szegedi
January 1986, Lung,
I Csipô, and L Czirják, and S Szántó, and L Szerafin, and S Sipka, and G Szegedi
August 1991, Atherosclerosis,
I Csipô, and L Czirják, and S Szántó, and L Szerafin, and S Sipka, and G Szegedi
June 2001, Clinical and experimental immunology,
I Csipô, and L Czirják, and S Szántó, and L Szerafin, and S Sipka, and G Szegedi
March 1995, Immunological investigations,
I Csipô, and L Czirják, and S Szántó, and L Szerafin, and S Sipka, and G Szegedi
January 2009, Clinical and experimental rheumatology,
I Csipô, and L Czirják, and S Szántó, and L Szerafin, and S Sipka, and G Szegedi
October 2018, World journal of pediatrics : WJP,
I Csipô, and L Czirják, and S Szántó, and L Szerafin, and S Sipka, and G Szegedi
January 2011, Environmental toxicology and pharmacology,
I Csipô, and L Czirják, and S Szántó, and L Szerafin, and S Sipka, and G Szegedi
January 2021, Medical principles and practice : international journal of the Kuwait University, Health Science Centre,
I Csipô, and L Czirják, and S Szántó, and L Szerafin, and S Sipka, and G Szegedi
January 2017, Clinical rheumatology,
I Csipô, and L Czirják, and S Szántó, and L Szerafin, and S Sipka, and G Szegedi
April 1992, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!